CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Mortality Risk Assessment

Background:

• High-density lipoprotein cholesterol (HDL-C) was considered an independent cardiovascular risk predictor, even with statin therapy.
• Recent trials have questioned the

Purpose of the Study:

• To clarify the association between HDL-C levels and cause-specific mortality using data from the CANHEART study.
• To evaluate HDL-C's role as a risk marker versus a direct cause of cardiovascular disease.

Main Methods:

• Analysis of observational data from the CANHEART study.
• Assessment of the relationship between HDL-C levels and cardiovascular, cancer, and non-CV/non-cancer mortality.

Main Results:

• Lower HDL-C levels were independently linked to increased risk of cardiovascular, cancer, and non-CV/non-cancer mortality.
• Similar associations were observed between HDL-C and both CV and non-CV outcomes.

Conclusions:

• HDL-C levels appear to be a marker of overall health risk rather than a specific causal factor for cardiovascular disease.
• The findings suggest a broader role for HDL-C in predicting mortality across various causes.